Huihui Yue
Tongji Hospital(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, COVID-19 and healthcare impacts
Most-Cited Works
- → Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19(2020)511 cited
- → MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program(2021)219 cited
- → Clinical characteristics of 54 medical staff with COVID‐19: A retrospective study in a single center in Wuhan, China(2020)213 cited
- → The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak(2020)212 cited
- → Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis(2019)208 cited
- → Blockade of JAK2 protects mice against hypoxia‐induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation(2020)91 cited
- → Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature(2021)40 cited
- → Repurposed Tocilizumab in Patients with Severe COVID-19(2020)25 cited
- → MBD2 facilitates tumor metastasis by mitigating DDB2 expression(2023)20 cited